Top-Paying Oncology Specialties Worldwide in 2025

Top-Paying

SIOG and OncoDaily Announce Strategic Partnership to Advance Global Geriatric Oncology

SIOG

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology

Razelle Kurzrock: Our Commentary and Implications for Future Precision Studies

Razelle Kurzrock

Anirban Maitra: Encorafenib, Cetuximab, and Nivolumab in Microsatellite Stable BRAFV600E mCRC

Anirban Maitra

Minhua Chu: Rui Therapeutics Completed a Series A Financing Exceeding RMB 200 Million

Minhua Chu, Rui Therapeutics

Applications are Open for IDEA Program with Special QI Mentorship Opportunity - ASCO

IDEA Program

Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

OncoCalendar

Loading Events

« All Events

  • This event has passed.

Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM)

March 25 • 12:00 AM - March 29 • 12:00 AM
Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM)

Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM) will be held from March 25, 2025 – May 29, 2026. It’s a hybrid event and the offline venues will change either.

The Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM) is a joint collaboration between the European School of Oncology (ESO) and the University of Fribourg, Switzerland.  The programme will focus on the improvement on both the clinical and the scientific aspects of improving quality in the management of patients with lung cancer and other thoracic malignancies.  Upon successful completion of the programme, participants will obtain an academic certificate assigning 14 ECTS credits, equalling a work load of 420 hours and a diploma supplement by the University of Fribourg.